Turkovac
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | Inactivated |
Clinical data | |
Other names | ERUCOV-VAC |
Routes of administration | Intramuscular |
Legal status | |
Legal status |
Part ofa serieson the |
COVID-19 pandemic |
---|
![]() |
|
Medical response |
|
![]() |
Turkovac[1](pronunciation:['tɜ:rkəvæk]) is aCOVID-19 vaccinedeveloped byTurkish Ministry of HealthandErciyes University.
Clinical trials
[edit]In November 2020, TURKOVAC started on phase I trials with 44 participants in Turkey.[2]
In February 2021, TURKOVAC started on phase II trials with 250 participants in Turkey.[3]
In June 2021, TURKOVAC started on phase III trials with 40,800 participants in Turkey.[4]As of 2023[update]phase III trials continue.[5]
Authorization
[edit]On 25 November 2021, theTurkish Minister of Healthreported that Turkovac's application for emergency use authorization had been filed.[6]On 22 December, Turkish PresidentRecep Tayyip Erdoganannounced the emergency use approval of Turkovac.[7]
References
[edit]- ^Cakmak BN (22 June 2021)."Turkey names home-grown COVID-19 jab Turkovac".Anadolu Agency.
- ^Clinical trial numberNCT04691947for "Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC (ERUCOV-VAC)" atClinicalTrials.gov
- ^Clinical trial numberNCT04824391for "Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19" atClinicalTrials.gov
- ^"Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine".ClinicalTrials.gov.28 June 2021. NCT04942405.Retrieved29 June2021.
- ^"ClinicalTrials.gov".clinicaltrials.gov.Retrieved16 January2024.
- ^"Turkey issues emergency-use authorization for its domestically produced vaccine".The New York Times.22 December 2021.Retrieved28 December2021.
- ^"Turkey authorises use of own Turkovac Covid-19 vaccine".France 24.23 December 2021.Retrieved24 December2021.
![](https://upload.wikimedia.org/wikipedia/commons/thumb/3/32/Scholia_logo.svg/40px-Scholia_logo.svg.png)
Development | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Classes | |||||||||||
Administration | |||||||||||
Vaccines |
| ||||||||||
Inventors/ researchers | |||||||||||
Controversy | |||||||||||
Related | |||||||||||
|
![]() | This article about COVID-19 vaccines is astub.You can help Wikipedia byexpanding it. |
![]() | This article aboutvaccinesorvaccinationis astub.You can help Wikipedia byexpanding it. |
- Articles with short description
- Short description is different from Wikidata
- Use dmy dates from November 2023
- Drugs with non-standard legal status
- Infobox drug articles with non-default infobox title
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Articles containing unverified chemical infoboxes
- Drugs that are a vaccine
- Articles containing potentially dated statements from 2023
- All articles containing potentially dated statements
- All stub articles